Physician profile
Brian Scott Yee
NPI 1881891059
$11,840.98
in general payments reported to CMS, 2019-2025
26 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,078 · 2020: $383 · 2021: $3,294 · 2022: $1,003 · 2023: $3,048 · 2024: $1,540 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,539 · Travel and Lodging: $1,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,538.99 |
| Travel and Lodging | $1,544.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,703.25 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Spinal Simplicity, LLC | $2,212.29 | 2021-2022 | |
| Abbott Laboratories | $1,853.49 | 2019-2025 | Eterna, Proclaim, Nt2000ix |
| Medtronic USA, INC. | $1,683.83 | 2019-2020 | |
| Nalu Medical, INC. | $688.04 | 2021-2022 | |
| Medtronic, INC. | $667.39 | 2021-2022 | |
| Nevro Corp. | $635.64 | 2019-2023 | Senza |
| Curonix LLC | $406.50 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $297.57 | 2023 | Intracept |
| Vertos Medical, INC. | $179.46 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $113.74 | 2024 | Evoke |
| Avanos Medical | $106.13 | 2021 | |
| Arbor Pharmaceuticals, INC. | $42.08 | 2020 | |
| Orthogenrx INC. | $29.33 | 2019 | |
| Radius Health, INC. | $27.14 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $25.25 | 2019 | |
| Abbvie INC. | $23.20 | 2022 | |
| Bioventus LLC | $21.30 | 2022 | |
| Stryker Corporation | $21.01 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $20.95 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.99 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.28 | 2019 | |
| Xeris Pharmaceuticals, INC. | $14.23 | 2021 | |
| Zyla Life Sciences, INC. | $12.02 | 2020 | |
| Daiichi Sankyo INC. | $11.72 | 2019 | |
| Fidia Pharma USA INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.